High performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of vardenafil, sildenafil, tadalafil, testosterone and local anesthetics in cosmetic creams sold on the Internet web sites

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 3, 2009, Pages 362-369

  De Orsi, Daniela ^a   Pellegrini, Manuela ^a   Marchei, Emilia ^a   Nebuloni, Paolo ^a   Gallinella, Bruno ^a   Scaravelli, Giulia ^a   Martufi, Alessio ^a   Gagliardi, Luigi ^a   Pichini, Simona ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cosmetic creams; ESI MS; HPLC UV DAD; Local anaesthetics; PDE 5 inhibitors; Testosterone

Indexed keywords

ACETONITRILE; BENZOCAINE; BENZOIC ACID; COSMETIC; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHANOL; PRILOCAINE; PROCAINE; SILDENAFIL; TADALAFIL; TESTOSTERONE; TRIFLUOROACETIC ACID; VARDENAFIL; WATER;

ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREAM; DRUG DETERMINATION; DRUG INDICATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; ERECTILE DYSFUNCTION; FEMALE GENITAL SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNET; MARKETING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANESTHETICS, LOCAL; CARBOLINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COSMETICS; FEMALE; HUMANS; IMIDAZOLES; INTERNET; MALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SULFONES; TESTOSTERONE; TRIAZINES;

EID: 67650364365     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.05.022     Document Type: Article

References (19)

1. Speranza L., Franceschelli S., Pesce M., Vinciguerra I., Se Lutiis M.A., Grilli A., Felaco M., and Patrono A. Int. J. Immunopathol. Pharmacol. 21 (2008) 879-889
2. Andersson K.E. Pharmacol. Rev. 53 (2001) 417-450
3. Carson C.C., and Lue T.F. BJU Int. 96 (2005) 257-280
4. Laties A.M. Drug Saf. 32 (2009) 1-18
5. Briganti A., Salonia A., Gallina A., Saccà A., Montorsi P., Rigatti P., and Montorsi F. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction. Nat. Clin. Pract. Urol. 2 (2005) 239-247
6. Wright P.J. Int. J. Clin. Pract. 60 (2006) 967-975
7. Dunn M.E., Althof S.E., and Perelman M.A. Int. J. Impot. Res. 19 (2007) 119-123
8. Gresser U., and Gleiter C.H. Eur. J. Med. Res. 7 (2002) 435-446
9. Hellstrom W.J., Gittelman M., Karlin G., Segerson T., Thibonnier M., Taylor T., and Padma-Nathan H. Urology 61 (2003) 8-14
10. Gomaa A., Eissa M., and El-Gebaley A. Int. J. Impot. Res. 13 (2001) 93-99
11. Giuliano F., and Hellstrom W.J. BJU Int. 1002 (2008) 668-675
12. http://www.ec.europa.eu/enterprise/cosmetics/html/consolidated_dir.htm. (accesses March 2009).
13. Porrà R., Berri S., Gagliardi L., Chimenti P., Granese A., De Orsi D., Carpani I., and Tonelli D. Anal. Bioanal. Chem. 380 (2009) 767-772
14. De Cock K.J., Delbeke F.T., Van Eenoo P., Desmet N., Roels K., and De Backer P. J. Pharm. Biomed. Anal. 25 (2001) 843-852
15. Zou P., Oh S.S., Hou P., Low M.Y., and Koh H.L. J. Chromatogr. A 1104 (2006) 113-122
16. Gratz S.R., Flurer C.L., and Wolnik K.A. J. Pharm. Biomed. Anal. 36 (2004) 525-533
17. ICH Topic Q 2 B Validation of Analytical Procedures: Methodology, The European Agency for the evaluation of Medicinal Products. Available at: http://www.emea.eu.int/htms/human/ich/quality/ichfin.htm. November 1996, ICH Technical Coordination, London.
18. Guidance for Industry, Bioanalytical Method validation, US Department of Health and Human Services, Food and Drug Administration, May 2001. Available at: http://www.fda.gov/cder/guidance/4252fnl.htm.
19. De Orsi D., Pellegrini M., Pichini S., Mattioli D., Marchei E., and Gagliardi L. J. Pharm. Biomed. Anal. 48 (2008) 641-648